We believe that thyroid dysfunction can alter the expression of specific angiogenic factors (including sFlt-1, PlGF, and VEGF) and modify the immune cell profile at the maternal-fetal interface (particularly NK cells, macrophages, and T regulatory cells), creating a new framework for understanding and addressing thyroid-related reproductive diseases through targeted immunomodulatory strategies. This evidence concerns the gene VEGFA and reproductive system disorder.